Nodule and lipoma formation can occur rarely after an intramuscular influenza vaccination, particularly when administered ...

Prophylactic intramuscular vitamin K administration in newborns decreased from 2017 to 2024, according to a recent research ...

The subcutaneous formulation of the bispecific antibody reduces treatment time to 1 minute vs 2-4 hours with IV infusion.

The FDA has granted approval to a subcutaneous formulation of mosunetuzumab (Lunsumio VELO; Genentech/Roche) for the treatment of adult patients with relapsed or refractory (R/R) follicular lymphoma ...

The U.S. Food and Drug Administration has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and ...

A 4-year, $1.6 million grant will allow the university to expand programs designed to equip health care providers to respond ...

With daily visits up more than 100 percent and dozens of life-threatening overdoses linked to the centers, officials and ...

Attorney General William Tong announced the settlement Wednesday with nurse Dayna Giordano and her medical office for ...

The nurse did not seek or receive payment for the drugs, officials said, but wasted taxpayer money and medication due to "poor record-keeping." ...

Indivior PLC today announced results from a randomized, double-blind clinical trial published in JAMA Network Open. The study found that both the 100-mg and 300-mg monthly maintenance doses ...

Extended-release buprenorphine is approved as a once-monthly subcutaneous injection for the treatment of moderate-to-severe OUD. A previous study cited by the study authors had suggested that a higher ...